Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17117855 | ILLUMINATING DEVICE IMPLANTABLE IN A LIVING BEING | December 2020 | February 2024 | Allow | 39 | 4 | 0 | No | No |
| 17113443 | DEVICE AND METHOD FOR STIMULATING PHOTO BIOCHEMICAL SYNTHESIS OF VITAMIN D3-CHOLECALCIFEROL | December 2020 | December 2022 | Abandon | 25 | 2 | 0 | No | No |
| 17111530 | METHOD OF TREATMENT OR PREVENTION OF KELOIDS AND HYPERTROPHIC SCARS USING ELECTROMAGNETIC RADIATION | December 2020 | October 2024 | Abandon | 46 | 4 | 0 | Yes | No |
| 16953831 | PHOTOTHERAPY APPARATUS PREVENTING EYE EXPOSURE AND CONTROL METHOD THEREOF | November 2020 | June 2022 | Abandon | 19 | 1 | 0 | No | No |
| 16951403 | BEAM PROFILE CONVERTER, CATHETER DEVICE, AND LASER ABLATION DEVICE | November 2020 | March 2024 | Allow | 39 | 2 | 0 | No | No |
| 17089863 | Ophthalmological Device For Intra-Capsular Fragmentation of a Lens Nucleus | November 2020 | December 2024 | Allow | 49 | 4 | 0 | Yes | No |
| 17061212 | PORTABLE DEVICE FOR TREATING A PATIENT WITH LIGHT AND METHOD FOR OPERATING THE PORTABLE DEVICE | October 2020 | November 2023 | Abandon | 38 | 4 | 0 | Yes | No |
| 17031746 | SYSTEMS AND METHODS FOR MODULATING CYTOKINE ACTIVITY | September 2020 | January 2025 | Abandon | 52 | 4 | 0 | No | Yes |
| 17029466 | BIOINFORMATION ACQUIRING APPARATUS, BIOINFORMATION ACQUIRING METHOD, AND NON-TRANSITORY RECORDING MEDIUM | September 2020 | December 2023 | Allow | 39 | 3 | 0 | Yes | No |
| 17040264 | OPTICAL STIMULATION SYSTEM WITH AUTOMATED MONITORING AND METHODS OF MAKING AND USING | September 2020 | March 2023 | Abandon | 30 | 2 | 0 | No | No |
| 16979223 | PHOTOTHERAPY DEVICE INCLUDE TWO OR MORE LIGHT PADS AND A FLEXIBLE GARMENT | September 2020 | May 2024 | Allow | 44 | 3 | 0 | Yes | No |
| 17014201 | MYOPIA-PREVENTING ILLUMINATION APPARATUS FOR ILLUMINATING EYEBALLS AND SURROUNDING TISSUES VIA LIGHT THAT PENETRATING PERIORBITAL SKIN, SUBCUTANEOUS TISSUE,THEN PASS THROUGH CORNEA, IRIS, UVEA, SCLERA AND CHOROID | September 2020 | November 2022 | Abandon | 26 | 2 | 0 | No | No |
| 17008440 | CANCER TREATMENT SYSTEM | August 2020 | July 2023 | Abandon | 34 | 3 | 0 | Yes | No |
| 17002552 | Bolus Stimulation in a Neurostimulation Device Particularly Useful in Providing Sub-Perception Stimulation | August 2020 | March 2024 | Allow | 42 | 4 | 0 | No | Yes |
| 16975150 | DARK FIELD REFLECTOMETRY | August 2020 | May 2024 | Abandon | 45 | 5 | 0 | Yes | No |
| 16995272 | METHOD FOR CONTROLLING AN EYE SURGICAL LASER AND TREATMENT DEVICE | August 2020 | February 2024 | Allow | 42 | 3 | 0 | Yes | No |
| 16993287 | Sleep Quality Monitoring System for the Middle-aged and the Elderly | August 2020 | December 2023 | Abandon | 40 | 1 | 0 | No | No |
| 16987400 | INPUT DEVICE OF SURGICAL MANIPULATOR, ROBOT-ASSISTED SURGICAL SYSTEM, AND CONTROLLER | August 2020 | December 2024 | Allow | 52 | 5 | 0 | Yes | No |
| 16964966 | System for Performing Laser Therapy and Method Therefor | July 2020 | December 2023 | Allow | 41 | 4 | 0 | No | Yes |
| 16964829 | PHOTODYNAMIC THERAPY DEVICES, SYSTEMS AND METHODS | July 2020 | September 2023 | Allow | 38 | 5 | 0 | Yes | No |
| 16964234 | APPARATUS FOR CUTTING A HUMAN OR ANIMAL TISSUE COMPRISING AN OPTICAL COUPLER | July 2020 | August 2024 | Abandon | 49 | 5 | 0 | No | Yes |
| 16926653 | WEARABLE DEVICE FOR NON-INVASIVE THERAPY OF MAMMARY GLANDS | July 2020 | January 2023 | Abandon | 30 | 2 | 0 | No | No |
| 16961316 | DEVICE FOR REMOTELY MONITORING A PATIENT WITH CHRONIC HEART FAILURE, AND ASSOCIATED SYSTEM AND METHOD | July 2020 | July 2023 | Abandon | 36 | 1 | 0 | No | No |
| 16922732 | Lumbar Laser Traction and Lumbar Laser Decompression Therapy | July 2020 | October 2022 | Abandon | 27 | 2 | 0 | No | No |
| 16920263 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | July 2020 | October 2024 | Abandon | 52 | 4 | 0 | No | No |
| 16769436 | MICROLENS ARRAY, AND LASER BEAM HAND PIECE AND THERAPEUTIC LASER DEVICE COMPRISING SAME | June 2020 | February 2024 | Abandon | 44 | 5 | 0 | Yes | No |
| 16767277 | MODULATING NEURAL ACTIVITY IN BRAINSTEM CIRCUITRY WITH LIGHT | May 2020 | June 2023 | Allow | 36 | 4 | 0 | No | No |
| 16765150 | ILLUMINATION VARIABILITY REDUCTION IN LASER TREATMENT SYSTEMS | May 2020 | June 2024 | Abandon | 49 | 3 | 0 | Yes | No |
| 16758832 | SYSTEM AND METHOD FOR REPOSITIONING INPUT CONTROL DEVICES | April 2020 | May 2024 | Allow | 49 | 5 | 0 | Yes | No |
| 16849774 | CUSTOMIZABLE PATCHES | April 2020 | July 2024 | Abandon | 51 | 4 | 0 | Yes | No |
| 16841073 | STRAIN GAUGE ASSEMBLY FORMED OF COMPONENTS HAVING TWO DIFFERENT STIFFNESSES | April 2020 | October 2023 | Abandon | 42 | 2 | 0 | No | No |
| 16753706 | PATIENT INTERFACE SYSTEM, METHOD FOR COUPLING A PATIENT INTERFACE TO A PATIENT INTERFACE HOLDER, PATIENT INTERFACE, AND PATIENT INTERFACE HOLDER | April 2020 | May 2023 | Allow | 38 | 3 | 0 | Yes | No |
| 16753340 | GLASSES PROVIDED WITH A PHOTON SOURCE, SYSTEM COMPRISING SUCH GLASSES AND USE OF SUCH GLASSES IN PHOTOTHERAPY | April 2020 | December 2021 | Abandon | 20 | 1 | 0 | Yes | No |
| 16829978 | SYSTEM AND METHOD FOR DETECTING AND PREDICTING AN OCCURRENCE OF CARDIAC EVENTS FROM ELECTROCARDIOGRAMS | March 2020 | December 2022 | Abandon | 33 | 1 | 0 | No | No |
| 16644553 | ROBOTIC SYSTEM FOR MINIMALLY INVASIVE SURGERY | March 2020 | September 2024 | Allow | 54 | 5 | 0 | Yes | No |
| 16779368 | SYSTEMS AND METHODS FOR PAIN MANAGEMENT | January 2020 | October 2023 | Abandon | 44 | 2 | 0 | No | No |
| 16741258 | Prescribed Neuromodulation Dose Delivery | January 2020 | January 2024 | Abandon | 48 | 4 | 0 | Yes | No |
| 16741196 | Spinal Cord Stimulation Occurring Using Monophasic Pulses of Alternating Polarities and Passive Charge Recovery | January 2020 | July 2023 | Allow | 43 | 3 | 0 | Yes | No |
| 16741242 | Tools To Assist Spinal Cord Stimulation Self-Reprogramming | January 2020 | December 2023 | Allow | 48 | 4 | 0 | Yes | Yes |
| 16741171 | Spinal Cord Stimulation for Dorsal Column Recruitment or Suppression Using Anodic and Cathodic Pulses | January 2020 | May 2024 | Allow | 52 | 6 | 0 | Yes | No |
| 16741214 | Therapy Implemented Using Different Sub-Perception Neuromodulation Types | January 2020 | October 2023 | Allow | 45 | 3 | 0 | No | Yes |
| 16738786 | Fitting Algorithm to Determine Best Stimulation Parameter from a Patient Model in a Spinal Cord Stimulation System | January 2020 | December 2023 | Allow | 47 | 4 | 0 | Yes | Yes |
| 16627425 | FACE-WEARABLE RHINITIS TREATMENT DEVICE USING LIGHT THERAPY | December 2019 | March 2022 | Abandon | 27 | 1 | 0 | No | No |
| 16711052 | SHIELDING FOR WRISTED INSTRUMENTS | December 2019 | January 2024 | Allow | 49 | 4 | 0 | Yes | No |
| 16687133 | PROBE UNIT AND ACOUSTIC WAVE RECEIVING SYSTEM | November 2019 | December 2021 | Abandon | 25 | 1 | 0 | No | No |
| 16687156 | TRUE ONSET IDENTIFICATION | November 2019 | July 2023 | Allow | 44 | 4 | 0 | Yes | No |
| 16614640 | SYSTEM AND METHODS FOR TREATING SKIN | November 2019 | January 2024 | Allow | 50 | 4 | 0 | Yes | No |
| 16609916 | PHYSIOLOGICAL INFORMATION TRANSMISSION SYSTEM, PHYSIOLOGICAL INFORMATION DETECTION SENSOR, INFORMATION PROCESSING APPARATUS, AND PHYSIOLOGICAL INFORMATION TRANSMISSION METHOD | October 2019 | February 2024 | Allow | 51 | 6 | 0 | No | No |
| 16596911 | METHOD OF TRANSMISSION BY A WATCH OF AN INFORMATION MESSAGE RELATING TO AN ASSESSMENT OF THE SLEEP QUALITY OF A USER OF SAID WATCH | October 2019 | January 2025 | Allow | 60 | 7 | 0 | Yes | No |
| 16582062 | PHOTOTHERAPY DEVICE AND PHOTOTHERAPY METHOD | September 2019 | October 2024 | Abandon | 60 | 6 | 0 | Yes | No |
| 16486136 | IMPROVED LIGHT THERAPY SYSTEM AND METHODS OF USE | August 2019 | June 2023 | Allow | 46 | 3 | 0 | Yes | Yes |
| 16527962 | SYSTEMS, DEVICES, AND RELATED METHODS FOR LASER LITHOTRIPSY | July 2019 | March 2024 | Allow | 55 | 5 | 0 | Yes | No |
| 16477798 | UVB LIGHT THERAPY FOR IMMUNE DISORDERS | July 2019 | October 2021 | Abandon | 27 | 1 | 0 | No | No |
| 16506415 | Interchangeable Tool Handle | July 2019 | March 2024 | Allow | 56 | 4 | 0 | Yes | No |
| 16505680 | Smart Surgical Laser Tissue Sealing And Cutting Apparatus With Optical Fiber Guided Sensors | July 2019 | November 2021 | Abandon | 28 | 1 | 0 | No | No |
| 16503892 | DIRECTIONAL ELECTRICAL STIMULATION LEADS, SYSTEMS AND METHODS FOR SPINAL CORD STIMULATION | July 2019 | April 2023 | Abandon | 45 | 4 | 1 | Yes | No |
| 16502973 | Methods, Systems, and Devices that Estimate Remaining Longevity of an Implanted Medical Device with Improved Accuracy | July 2019 | June 2023 | Allow | 47 | 4 | 0 | Yes | No |
| 16502084 | HEADER HAVING RADIOGRAPHIC MARKER | July 2019 | December 2023 | Allow | 54 | 6 | 0 | No | Yes |
| 16460569 | SUPERVISED CARDIAC EVENT DETECTION | July 2019 | June 2023 | Allow | 48 | 5 | 0 | Yes | No |
| 16460275 | STRESS BIOMARKER AND HEALTH INDICATOR SYSTEM | July 2019 | September 2024 | Allow | 60 | 6 | 1 | Yes | Yes |
| 16460858 | VENOUS ABLATION CATHETER AND METHOD | July 2019 | July 2024 | Abandon | 60 | 5 | 0 | No | No |
| 16438433 | UPCONVERSION FLUORESCENCE-BASED PHOTOBIOMODULATION | June 2019 | March 2023 | Abandon | 45 | 1 | 0 | No | No |
| 16463925 | SYSTEMS, METHODS, AND FLEXIBLE OPTICAL WAVEGUIDES FOR SCLERAL CROSSLINKING | May 2019 | July 2023 | Abandon | 50 | 4 | 0 | No | No |
| 16338880 | A HAIR CUTTING DEVICE USING PULSED RADIATION | April 2019 | March 2022 | Abandon | 36 | 1 | 0 | No | No |
| 16179003 | DECISION SUPPORT SYSTEM FOR NOTIFYING OF VARIANCES | November 2018 | October 2024 | Abandon | 60 | 4 | 0 | Yes | No |
| 15757765 | THERAPEUTIC SUBSTANCE DELIVERY DEVICE AND THERAPEUTIC SUBSTANCE DELIVERY KIT | March 2018 | May 2023 | Allow | 60 | 4 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SUNDARESAN, RANJANI MARI.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 46.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner SUNDARESAN, RANJANI MARI works in Art Unit 3792 and has examined 66 patent applications in our dataset. With an allowance rate of 48.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 45 months.
Examiner SUNDARESAN, RANJANI MARI's allowance rate of 48.5% places them in the 12% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SUNDARESAN, RANJANI MARI receive 3.47 office actions before reaching final disposition. This places the examiner in the 91% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by SUNDARESAN, RANJANI MARI is 45 months. This places the examiner in the 14% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +40.0% benefit to allowance rate for applications examined by SUNDARESAN, RANJANI MARI. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 19.0% of applications are subsequently allowed. This success rate is in the 22% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 12.2% of cases where such amendments are filed. This entry rate is in the 14% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 100% percentile among all examiners. Of these withdrawals, 55.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 53% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.